MAVIK Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Mavik, and what generic alternatives are available?
Mavik is a drug marketed by Abbvie and is included in one NDA.
The generic ingredient in MAVIK is trandolapril. There are ten drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the trandolapril profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mavik
A generic version of MAVIK was approved as trandolapril by AUROBINDO PHARMA on June 12th, 2007.
Summary for MAVIK
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 75 |
Patent Applications: | 4,558 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in MAVIK? | MAVIK excipients list |
DailyMed Link: | MAVIK at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for MAVIK
Paragraph IV (Patent) Challenges for MAVIK
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
MAVIK | Tablets | trandolapril | 1 mg, 2 mg and 4 mg | 020528 | 1 | 2004-10-04 |
US Patents and Regulatory Information for MAVIK
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | MAVIK | trandolapril | TABLET;ORAL | 020528-001 | Apr 26, 1996 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abbvie | MAVIK | trandolapril | TABLET;ORAL | 020528-002 | Apr 26, 1996 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abbvie | MAVIK | trandolapril | TABLET;ORAL | 020528-003 | Apr 26, 1996 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MAVIK
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | MAVIK | trandolapril | TABLET;ORAL | 020528-002 | Apr 26, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie | MAVIK | trandolapril | TABLET;ORAL | 020528-001 | Apr 26, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie | MAVIK | trandolapril | TABLET;ORAL | 020528-001 | Apr 26, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MAVIK
See the table below for patents covering MAVIK around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Czechoslovakia | 9104095 | ⤷ Try a Trial | |
Austria | 47838 | ⤷ Try a Trial | |
Japan | S60231696 | TREATMENT FOR CARDIAC DYSFUNCTION | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for MAVIK
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0084164 | SPC/GB93/146 | United Kingdom | ⤷ Try a Trial | SPC/GB93/146:, EXPIRES: 20070218 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |